Stockscreener 앱 받기
1.46
7.01%
-0.11
시간 외 거래:
1.42
-0.04
-2.74%
전일 마감가:
$1.57
열려 있는:
$1.47
하루 거래량:
413.97K
Relative Volume:
0.75
시가총액:
$5.87M
수익:
-
순이익/손실:
$-7.10M
주가수익비율:
-0.2752
EPS:
-5.3059
순현금흐름:
$-8.30M
1주 성능:
+32.73%
1개월 성능:
+10.61%
6개월 성능:
+13.18%
1년 성능:
-74.87%
1일 변동 폭
$1.40
$1.55
1주일 범위
$1.06
$1.62
52주 변동 폭
$0.9509
$6.2248
Dermata Therapeutics Inc Stock (DRMA) Company Profile
명칭
Dermata Therapeutics Inc
전화
(858)-223-0882
주소
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Compare DRMA vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
1.46 | 5.55M | 0 | -7.10M | -8.30M | -5.3059 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Dermata Therapeutics Inc 주식(DRMA)의 최신 뉴스
Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Sahm
DRMA|Dermata Therapeutics Inc|Price:1.370|Chg%:+0.290 - TradingKey
Dermata Therapeutics Stock Surges 27% Pre-Market: Why is it Moving? - webull.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Unusual volume stocks are being observed in Wednesday's session. - ChartMill
The market is filled with gapping stocks in Wednesday's session. - ChartMill
DRMA Stock In Focus As Dermata Pivots To Direct-To-Consumer Skincare - timothysykes.com
DRMA Stock Draws Traders As Dermata Pivots To Skincare - StocksToTrade
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
DRMA Stock Draws Traders As Dermata Pivots To Skincare Launch - StocksToTrade
DERMATA THERAPEUTICS ($DRMA) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Dermata Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Trending Stocks Today | Dermata Therapeutics Soars 35.18% Post-Market - Moomoo
DRMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Dermata Therapeutics (DRMA) faces going concern warning amid higher losses and cash burn - Stock Titan
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026 - ACCESS Newswire
Dermata's Tome Skincare Product Is Designed for Once-Weekly Use - Stock Titan
$Dermata Therapeutics (DRMA.US)$ - Moomoo
Dermata Therapeutics Inc expected to post a loss of 55 cents a shareEarnings Preview - TradingView
Dermata Therapeutics Inc (NASDAQ: DRMA) Share Price, DRMA Stock News, DRMA Share Price & Updates - Kalkine
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment - webull.com
Dermata Therapeutics Launches Tome Foundational Skincare Line - TipRanks
Dermata to launch first consumer skincare product Aug. 25 - Investing.com
Dermata to launch first consumer skincare product Aug. 25 By Investing.com - Investing.com South Africa
Dermata's planned $178 skincare set includes four weekly treatments - Stock Titan
Dermata’s First Consumer Brand Wants to Function as ‘Microneedling Lite’ - WWD
Dermata Therapeutics, Inc. Revenue Breakdown – NASDAQ:DRMA - TradingView
Dermata Therapeutics Inc (DRMA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
DRMA|Dermata Therapeutics Inc|Price:1.290|Chg%:-0.030 - TradingKey
Dermata Therapeutics Inc (DRMA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Dermata Therapeutics, Inc. Revenue Breakdown – BOATS:DRMA - TradingView
Dermata Therapeutics Inc (DRMA) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
TradingKey - TradingKey
Dermata Therapeutics, Inc. Revenue Breakdown – BOATS:DRMAW - TradingView
Price to earnings forward of Dermata Therapeutics, Inc. – NASDAQ:DRMAW - TradingView
Price to sales forward of Dermata Therapeutics, Inc. – NASDAQ:DRMAW - TradingView
Enterprise value to revenue forward of Dermata Therapeutics, Inc. – NASDAQ:DRMAW - TradingView
Price to book forward of Dermata Therapeutics, Inc. – NASDAQ:DRMAW - TradingView
Dermata Therapeutics (DRMA) Drops 7.5% as Stock Nears Support at $1.23Analyst Upgrade Stocks - dars.gov.et
DRMA Q1 2026 Earnings: EPS Surprise of 11.21% Beats Estimates Amid No Revenue GenerationDividend Earnings Report - dars.gov.et
Dermata Therapeutics Warrants Hold at $0.01 Amidst Minimal ActivityUnusual Call Volume - dars.gov.et
Dermata Therapeutics Inc Warrant 2021- on Dermata Therapeutics Financial Disclosures & SEC Filings - TradingView
Dermata Therapeutics Warrant (DRMAW) Holds at $0.01 – Warrants Remain at Key Support LevelCombination Correction - dars.gov.et
Price to earnings forward of Dermata Therapeutics, Inc. – BOATS:DRMAW - TradingView
Dermata Therapeutics, Inc. Actuals & Estimates (NASDAQ:DRMA) - TradingView
Enterprise value to EBIT forward of Dermata Therapeutics, Inc. – NASDAQ:DRMA - TradingView
DRMA Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Dermata Therapeutics, Inc. – NASDAQ:DRMA - TradingView
Price to earnings forward of Dermata Therapeutics, Inc. – NASDAQ:DRMA - TradingView
Dermata Therapeutics Inc (DRMA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Dermata Therapeutics Inc (DRMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Dermata Therapeutics Inc 주식 (DRMA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs |
Feb 17 '26 |
Buy |
1.27 |
1,000 |
1,270 |
1,012 |
0.52%
0.07%
자본화:
|
볼륨(24시간):